by Clinical Neuropsychologist Online | Tuesday, July 7, 2026 | Dementia
Abstract INTRODUCTION The prognostic value of emerging dementia-related blood-based biomarkers for post-stroke cognitive impairment is poorly understood. We addressed this critical gap in this systematic review. METHODS Four databases were searched in March 2025 for...
by Clinical Neuropsychologist Online | Tuesday, July 7, 2026 | Dementia
Abstract INTRODUCTION Primary Progressive Aphasia (PPA) clinical syndromes do not align consistently with underlying pathology. This study aimed to identify language markers for specific neuropathologies using both standard clinical tests and narrative speech...
by Clinical Neuropsychologist Online | Sunday, July 5, 2026 | Dementia
Abstract The Dame Barbara Windsor Dementia Goals Programme was launched by the UK Government to accelerate the development and delivery of new treatments for dementia. We present the recommendations from the Scientific Advisory Board, to enable timely access to...
by Clinical Neuropsychologist Online | Sunday, July 5, 2026 | Dementia
Alzheimer’s &Dementia, Volume 22, Issue 7, July 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | July 5, 2026 Neuro-Dementia Previous...
by Clinical Neuropsychologist Online | Friday, July 3, 2026 | Dementia
Abstract INTRODUCTION Secondary prevention treatments for Alzheimer’s disease (AD) that are currently in late-stage clinical trials may preserve productivity and workforce participation. METHODS Using the nationally representative Health and Retirement Study...
by Clinical Neuropsychologist Online | Friday, July 3, 2026 | Dementia
Abstract INTRODUCTION Neurodegenerative diseases often involve overlapping alpha-synuclein (asyn), amyloid beta, and tau proteinopathies, yet the mechanisms, impact, and directionality of their interactions remain unclear. METHODS We induced brain-wide neuronal...
